Robert Ferris
MD, PhD
Director, UPMC Hillman Cancer Center
👥Biography 个人简介
Dr. Robert Ferris is director of UPMC Hillman Cancer Center and a leading clinical investigator in checkpoint immunotherapy. He contributed to the clinical development of anti-LAG-3 relatlimab and was involved in the RELATIVITY-047 trial that established nivolumab plus relatlimab (Opdualag) as a new first-line option for advanced melanoma. His research focuses on combination checkpoint blockade strategies and predictive biomarkers for dual checkpoint therapy.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Robert Ferris 的研究动态
Follow Robert Ferris's research updates
留下邮箱，当我们发布与 Robert Ferris（University of Pittsburgh Medical Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment